article thumbnail

[UPCKat] Access to confidential information by parties and the public in the UPC

The IPKat

The UPCKat trying to keep confidential information confidential in the UPC As part of our UPCKat reporting on the latest UPC developments, the IPKat brings readers a roundup of how the UPC is treating confidentiality and third party access to court documents.

article thumbnail

NDA: An Effective Way to Protect Confidential Information

LexBlog IP

Shi then left Elation to start a business marketing “similar, if not identical software” using replicated source code. A settlement agreement was reached where Elation could inspect the software developed by Shi and prevent the use of any trade secrets or confidential information.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Protecting Your IP & Confidential Info

Above the Fold

In a world where non-compete agreements are being curtailed or outright banned, companies need to enhance their use of other ways to protect their intellectual property and confidential information when their employees leave to go work for competitors. developed during the term of employment.

article thumbnail

How do I Protect my Confidential Information in Litigation?

LexBlog IP

If they see it, they might found out about a corner of the market that they have overlooked, a technology The trouble is, you have internal documents relevant to the trial that you really don’t want the other side to see.

article thumbnail

Apple Watch Stays on US Market, But Pulse-Ox Disabled Pending Appeal

Patently-O

The image below comes from Apple Briefing from last week that attempted to keep information about the redesign confidential. So, bottom line here is that the Apple Watch stays on the market, but only if it disables the Pulse-Oximetry functionality.

Marketing 113
article thumbnail

Undisclosed Information and Patents

IP and Legal Filings

Extent of Undisclosed Information. The protection of undisclosed information is an important facet for pharmaceutical industries, R&D Institutions, and other agencies. Trade-Related Aspects of Intellectual Property Rights (TRIPS) does provide a provision for the protection of undisclosed information.

article thumbnail

A Hospital Mailed a Patient’s Confidential Diagnosis to a Rando. You’ll Never Guess What Happened Next–ZD v. Community Health

Technology & Marketing Law Blog

Why did Jonae post ZD’s confidential diagnosis on Facebook? There were two obvious breakdowns that led to this bizarre and highly unfortunate set of events: (1) the hospital sending confidential medical information to a non-patient, and (2) the letter recipient publicizing the confidential medical information.